The Yale Center for Molecular Discovery. A Core Research Facility at Yale s West Campus
|
|
- Sybil Burke
- 6 years ago
- Views:
Transcription
1 The Yale Center for Molecular Discovery A Core Research Facility at Yale s West Campus
2 This is one-stop shopping for scientists who are looking to take the next step in advancing their research. Scott Strobel, vice president for West Campus planning and program development
3 Making sense of life s complexity The adult human body contains more than 60 trillion cells, organized into 300 distinct cell types that carry out the many processes of life replicating DNA, distributing new proteins, controlling cell division, or enabling cell-to-cell communication. Yet within this complexity, a single molecule can have a profound impact. Scientists have long known that mutations in specific genes can cause devastating diseases like sicklecell anemia, hemophilia, or cystic fibrosis. Equally important, small molecules can attach to the surface of a cell or even pass through membranes to impact the cell s inner workings, with profound implications for human development and health. This is the province of the Yale Center for Molecular Discovery (YCMD). A core facility on Yale s West Campus, the Center is uniquely equipped to study how chemical compounds drive cellular machinery and to ask what happens to the cell when specific genes are switched o. The answers not only expand our basic knowledge of biology, but also may lead to new treatments in the fight against hereditary diseases, drug-resistant bacteria, and cancer. Accelerating the pace of discovery At the heart of the Center is the ability to scale up a laboratory investigation, moving from a handful of samples per day typical for academic laboratories to tens of thousands per day, a level once associated only with big pharmaceutical companies. This scale-up, so critical to the translation of basic research into new medicines, requires an innovative organizational model as well as state-of-the-art equipment. The YCMD is sta ed with experts drawn from both academic laboratories and biopharmaceutical companies, bringing in-depth knowledge of tools and techniques not usually found in a university setting. Further, the Center is the only core service facility of its kind to select its projects through a peer-review process, ensuring that the most promising ideas are given top priority. Once a project is selected, the Yale faculty researcher is paired with a YCMD sta member, and research proceeds collaboratively. The team uses a suite of automated liquid dispensers, plate readers, and microscopes to rapidly process large numbers of samples, while retaining the high level of quality that is the hallmark of Yale s scientific research. Microbial Diversity Chemical Biology Systems Biology Core Facilities Cancer Biology Energy Sciences The 136-acre West Campus is home to an integrated cluster of research institutes in the areas of chemical biology, cancer, nanobiology, systems biology, microbial diversity, and energy sciences. Supporting this work are four core facilities shared by Yale s science faculty: Yale Center for Molecular Discovery Yale Center for Genome Analysis High Performance Computing Center West Campus Analytical Chemistry Core Nanobiology These interrelated institutes and core facilities sustain a multidisciplinary approach to today s most pressing questions of human sustainability health, the environment, and energy and advance Yale University as a national leader in scientific teaching and research. Taken together, the capabilities of the YCMD open an extraordinary window into the living cell, with implications across the areas of natural science, human health, and the discovery of novel medical treatments. Only a handful of universities around the world have access to this combination
4 of expertise and technology, and at West Campus, Yale is determined to sustain and expand the YCMD at the absolute cutting edge. Donor support will play an essential role in this mission, not only enabling new discoveries but also distinguishing Yale in the top echelon of research institutions. A focus on tomorrow s drug pipeline What makes a good candidate for drug research and development? Yale s Center for Molecular Discovery has been designed to answer this question, with tools to not only find active compounds, but also map out how they work, so that the most promising can be advanced to clinical trials. The Yale Center for Molecular Discovery has a major educational mission, preparing undergraduates, graduate students, and postdoctoral fellows for leadership positions in tomorrow s research laboratories. The Center is staffed by researchers who are wellversed in the approaches used in the pharmaceutical industry. At the same time, it draws from Yale s leadership in basic and applied biology, chemistry, and engineering departments and helps to sustain a growing program of clinical research. This high-tech, multidisciplinary setting supports the cutting edge of biomedical education as well as research. The Center conducts more than eighty projects per year, each involving students, and it sponsors a summer internship to provide undergraduates with a meaningful research experience. A series of nanocourses helps students and faculty navigate the challenges of translating basic research results into candidates for drug discovery. For Yale, this early-stage research and development work is more essential than ever. A pharmaceutical company needs a solid foundation before it will commit a compound to the drug discovery pipeline: What is the structure of the chemical compound, how does it interact with the cell, and what will it do in the body? Today, just a few hundred compounds are well understood. There remains a vast knowledge gap that must be filled what drug companies call the valley of death that distinguishes our expanding knowledge of how the body works from our ability to intervene and correct known defects. Increasingly, the ability to bridge this divide is something that only the nation s top academic institutions can accomplish. Large pharmaceutical companies facing new economic constraints have dramatically curtailed their funding of major research and development e orts. Leading universities like Yale must build the capacity to conduct translational research on a new scale, or the pipeline of critical new medicines will begin to run dry. Yale biologist Craig Crews, director of the YCMD, has a deep understanding of this landscape. In July 2012, Crews completed the goal of successfully shepherding a compound from the lab bench into the clinic. His cancer drug, Carfilzomib (Kyprolis), was approved by the US Food and Drug Administration to treat recurrent multiple myeloma, a blood disorder, without the painful complications that often accompanied earlier therapies. Building on this expertise, Crews now helps fellow researchers find their own paths to drug discovery, using high-throughput technologies to characterize a novel chemical, learn how that chemical a ects cellular processes, and envision how it might be repurposed to cure disease in the human body. 2
5 Only a select few compounds have the potential to impact disease in a way that is targeted, safe, and affordable, and fewer still will actually survive the long and expensive path to becoming an approved drug. 3
6 Leaders in Discovery Above: Advanced molecular modeling graphics allow the detailed examination of Adenosine monophosphate (AMP) interacting with a new target protein. Opposite page, top: A researcher prepares copies of master assay plates using the TECAN liquid handler. Opposite page, right: The molecular interaction of Streptavidin with its natural ligand Biotin serves as the basis of many biochemical techniques at the Center. 4
7 Yale is widely known for its strength in the life sciences, spanning basic biology, biomedical engineering, and medicine. In labs across the University, scientists are now turning to the Yale Center for Molecular Discovery, illustrating the promise of high-throughput screening technologies in solving urgent problems in areas from the environment to human health. Neuroscientist Stephen Strittmatter studies key genes and proteins implicated in devastating neurological conditions. With the support of the YCMD, he is searching for drug candidates that can arrest the progress of Alzheimer s disease, and he hopes to understand the action of compounds that prevent the regeneration of adult neurons research with promise for victims of stroke or traumatic spinal cord injury. Diane Krause seeks to pinpoint the molecular mechanisms that regulate the formation of blood cells. Her work at the YCMD, screening stem cells derived from bone marrow, is shedding light on the processes of self-renewal and di erentiation findings that may lead to improved strategies for bone marrow and stem cell transplantation as well as novel therapies for treating leukemia and lymphoma. What new functions can be found for engineered RNA and DNA? And can the ancient functions of dormant nucleic acids be discovered and put to use? These are the big questions that inspire Ronald Breaker s research. Of special interest are ribozymes and riboswitches RNA molecules that catalyze chemical reactions or that serve as chemical sensors and gene control elements. With help from the YCMD, the Breaker lab is investigating the potential use of riboswitches in a new class of antibiotics that circumvent bacteria s ability to develop resistance. 5
8 David F. Stern and Marcus Bosenberg investigate ways to combine the actions of di erent chemotherapeutic drugs to provide a more safe and e ective means of combating cancer. Their research uses tumor samples and treatment models taken directly from the Yale Cancer Center, advancing our knowledge of combination therapy while having immediate clinical impacts. Michael Kinch, managing director of the YCMD, leads a scientific team of ten investigators spanning academia and the pharmaceutical industry. Their mission is to assist Yale faculty members who want to use high-throughput screening tools not found in conventional academic labs. These include extensive compound libraries, cutting-edge robotics, highresolution imaging, and state-of-the-art computational approaches that dramatically accelerate the discovery process. We want to provide to the Yale faculty the advice and equipment they need to begin the journey from discovery to development of new drugs, says Kinch. This work can speed the translation of basic research and broaden the attractiveness of Yale as a partner of choice for biopharmaceutical companies. Susan Baserga is interested in the nucleolus a structure within the cell s nucleus composed of proteins and nucleic acids. A healthy cell has two or three of these structures, which act as essential ribosome producing machines. In contrast, a cancer cell may have too many nucleoli, or perhaps a single, oversized one. Baserga is using the tools of the YCMD to identify proteins that lead to these unhealthy nuclear formations, in hopes of finding a druggable target in the fight against melanoma and other cancers. Jo Handelsman takes a big-picture view of biology as a pioneer of metagenomics, an emerging discipline that looks at the diversity of genes found in specimens across a whole ecosystem. Opening a window on a vast microbial world that was previously inaccessible, metagenomics has both theoretical and practical applications, allowing Handelsman to look for new antibiotics, for example, or to explore the genetic basis of antibiotic resistance. Kinch has a background well suited to his leadership role. From 1996 to 2001, he was a tenured professor at Purdue University, where he focused on cancer research. In 2001, he was recruited to lead the departments of cancer biology and translational sciences at MedImmune, a successful biotechnology company. He later served as chief scientific o cer at Functional Genetics, which pioneered new approaches for treating infection by HIV, influenza, Ebola, and other viruses. He came to Yale in 2010 to help advance Yale s West Campus initiatives. 6
9 Above: The novel protein NPP4, discovered at Yale, is examined in preparation for molecular docking. Opposite page, bottom: Natural products are extracted from a variety of cultured organisms and tested in novel drug target screens. 7
10 To learn more For more information about Yale s West Campus, please visit: Photo Credits All photography and molecular graphics by Denton Hoyer unless otherwise noted. Michael Marsland: page 8 06/13.5 M Printed on 30% recycled, postconsumer-waste paper
11
12
Harvard Stem Cell Institute
Welcome to the Harvard Stem Cell Institute The 1000+ scientists in the HSCI network share one goal: finding cures for human diseases. We aim to: Stimulate healing in patients by harnessing the potential
More informationEducation Critical to Stem Cell Therapy Pipeline
June 2016 Education Critical to Stem Cell Therapy Pipeline Don L. Gibbons Senior Science and Education Communication Officer ABOUT California Institute for Regenerative Medicine (CIRM) CIRM is California
More informationMAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE
MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC
More informationLesson Overview. Studying the Human Genome. Lesson Overview Studying the Human Genome
Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful
More informationWhat are the origins of medical practice? Humans have been involved with medical biotechnology
Name: Score: / Quiz 8 on Medical Biotechnology Part 1 What are the origins of medical practice? Humans have been involved with medical biotechnology A. since the cloning of the insulin gene in the 1980s
More informationTHE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE
THE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE The promise of genomics to revolutionize medicine and to transform our understanding of life itself is one of the great opportunities of our time.
More informationFrom Bench To Clinic : a personal journey Career Research Advancement Focused Training
From Bench To Clinic : a personal journey Career Research Advancement Focused Training February 13, 2018 Irina Tcherepanova Ph.D. Vice President of Translational Medicine Argos Therapeutics Inc. FDA view
More informationBIOMOLECULAR SCIENCE PROGRAM
Program Director: Michael Joesten Advances in biology, particularly at the cellular and molecular level, are changing the world that we live in. The basic knowledge of the way nature functions to create
More informationLesson 7A Specialized Cells, Stem Cells & Cellular Differentiation
Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation Learning Goals I can explain the concept of cell differentiation and cell specialization. I can explain how the cell structure relates
More informationWHAT IS BIOCHEMISTRY
WHAT IS BIOCHEMISTRY Each part of every living being is biochemically connected. Biochemistry is at the heart of life science. It is a fascinating, diverse and sprawling discipline; which makes it near
More informationINUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE
INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR > SOLUTIONS AND HOPE Millions of people worldwide suffer from deadly diseases, chronic conditions and congenital disorders
More informationUNIT MOLECULAR GENETICS AND BIOTECHNOLOGY
UNIT MOLECULAR GENETICS AND BIOTECHNOLOGY Standard B-4: The student will demonstrate an understanding of the molecular basis of heredity. B-4.1-4,8,9 Effective June 2008 All Indicators in Standard B-4
More informationA Report on the Molly and David Bloom Chair in Multiple Myeloma Research at the Princess Margaret Cancer Centre
A Report on the Molly and David Bloom Chair in Multiple Myeloma Research at the Princess Margaret Cancer Centre April 2013 Table of Contents 1 Introduction 2 Your Support 3 Thank you 10 The Princess Margaret
More informationStands for purpose. Molecular Horizons: Centre for Molecular & Life Sciences
Stands for purpose Molecular Horizons: Centre for Molecular & Life Sciences MOLECULAR HORIZONS Understanding life, one molecule at a time The molecular life sciences are at the forefront of scientific
More informationMedical Topics: Gene Therapy. E. Anne Jackson, FSA MAAA July 30, 2018
Medical Topics: Gene Therapy E. Anne Jackson, FSA MAAA July 30, 2018 Agenda Terminology Crash course in the science Existing FDA-approved gene therapies Underwriting implications 2 Terms related to high
More informationsocial, and population-based research conducted and supported by the National Institutes of Health (NIH). The
Statement by the Ad Hoc Group for Medical Research on FY 2015 Appropriations for the National Institutes of Health Submitted for the record on March 28, 2014, to the Subcommittee on Labor, Health and Human
More informationUNDERSTANDING GENETIC RESEARCH AND ALTERNATING HEMIPLEGIA OF CHILDHOOD. IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process
IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process Genetic discovery AHC Patients Need Help! Researchers collect data on AHC patients (observation) Researchers interpret and evaluate data AHC
More informationTHE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org
THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA themmrf.org ABOUT THE MULTIPLE MYELOMA RESEARCH FOUNDATION The Multiple Myeloma Research Foundation (MMRF) was established in 1998 by identical twin sisters
More informationVertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis
Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mrna Therapeutics for Cystic Fibrosis -Collaboration to explore use of mrna Therapeutics to treat the underlying cause of CF
More informationStem Cells: Introduction and Prospects in Regenerative Medicine.
Stem Cells: Introduction and Prospects in Regenerative Medicine www.gothamgazette.com/.../stemcell/stem_cell.jpg Ode to a Stem Cell, Part II by VCW There once was stem cell stuck in the hood Dividing endlessly,
More informationEXECUTIVE SUMMARY GLOBAL GENOMICS AND BIOINFORMATICS RESEARCH INSTITUTE. May 24, 2017
EXECUTIVE SUMMARY GLOBAL GENOMICS AND BIOINFORMATICS RESEARCH INSTITUTE May 24, 2017 Introduction to the Institute Inova Health System Foundation ( Inova ), The Rector and Visitors of the University of
More informationCapabilities & Services
Capabilities & Services Accelerating Research & Development Table of Contents Introduction to DHMRI 3 Services and Capabilites: Genomics 4 Proteomics & Protein Characterization 5 Metabolomics 6 In Vitro
More informationIntegration of FDSS7000 into a modular robotic system for Open Innovation drug discovery
Integration of FDSS7000 into a modular robotic system for Open Innovation drug discovery José Manuel Brea & María Isabel Loza BioFarma, Santiago de Compostela DRUG DISCOVERY OPEN INNOVATION CLOSED innovation
More informationGene therapy. Findings by Alert
Gene therapy Published Mar 21, 2000 Version 1 Findings by Alert Research in gene therapy has increased dramatically during the past 15 years, particularly in the United States. The research has encompassed
More informationThe NYSCF Research Institute
Regenerative Medicine Research Update Susan L. Solomon The NYSCF Research Institute New York Pharma Forum February 25, 2016 Regenerative Medicine Research Regenerative medicine uses laboratory grown human
More informationTranslational Research through Public-Private Partnerships. 65 th Annual Bohan Lecture. Scott J. Weir, PharmD, PhD 08 October 2011
Translational Research through Public-Private Partnerships 65 th Annual Bohan Lecture Scott J. Weir, PharmD, PhD 08 October 2011 Drug Focused Translational Research Translational Research Defined by the
More informationCase Study: Dr. Jonny Wray, Head of Discovery Informatics at e-therapeutics PLC
Reaxys DRUG DISCOVERY & DEVELOPMENT Case Study: Dr. Jonny Wray, Head of Discovery Informatics at e-therapeutics PLC Clean compound and bioactivity data are essential to successful modeling of the impact
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics If the 19 th century was the century of chemistry and 20 th century was the century of physic, the 21 st century promises to be the century of biology...professor Dr. Satoru
More informationFirst Place Essay. Katie P.
First Place Essay Katie P. Eighth Grade West Reading, PA 19611 Bioscience research is seeking information by exploring life's processes and diseases. It has helped many scientists understand how the body
More informationGenetic Engineering in Agriculture
Details Utah State University Engineering in This is a project resulting from the Engineering Workshop for Teachers to provide teaching materials for genetic engineering topics. Please direct any feedback
More informationUnderstanding brain diseases from stem cells to clinical trials
Understanding brain diseases from stem cells to clinical trials Alan Mackay Sim Griffith Institute for Drug Discovery Griffith University Brisbane, QLD Making ES cells Fertilise an egg Put in a dish Embryonic
More informationPresidential Commission for the Study of Bioethical Issues 2 nd meeting September
Presidential Commission for the Study of Bioethical Issues 2 nd meeting September 13 14 2010 David B. Weiner, Ph.D. Professor Department of Pathology and Laboratory Medicine University of Pennsylvania
More informationBasic Concepts and History of Genetic Engineering. Mitesh Shrestha
Basic Concepts and History of Genetic Engineering Mitesh Shrestha Genetic Engineering AKA gene manipulation, gene cloning, recombinant DNA technology, genetic modification, and the new genetics. A technique
More informationChapter 5 Learning Objectives
Schedule and Announcements Go over Exam 1 Look at Elodea (plant cells) Start Chapter 5 Quiz Thursday over lab material Science Café 2 Friday Don t forget- research plan for project is due Friday September
More informationInvesting in Discovery
Investing in Discovery The Impact of Basic Research and the Role of the National Institute of General Medical Sciences Jeremy M. Berg, Ph.D. Director National Institute of General Medical Sciences National
More informationPage 1 of 5 Message from the Director: As the summer kicks off, many of us will renew our focus on research and scholarship. Towards this goal, we draw your attention to a several upcoming events and opportunities
More informationChairman Cole, Ranking Member DeLauro and distinguished members of the
Fiscal Year 2019 House Appropriations Committee Subcommittee on Labor, Health and Human Services, Education and Related Agencies Appropriations Testimony Cynthia A. Bens, Senior Vice President, Public
More informationRobert J. Beall, PhD, President and Chief Executive Officer Cystic Fibrosis Foundation
Name and Organization: Robert J. Beall, PhD, President and Chief Executive Officer Cystic Fibrosis Foundation Subject of Testimony: Food and Drug Administration Funding for Fiscal Year 2013 Point of Contact:
More informationPioneering Clinical Omics
Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of
More informationStudying the Human Genome. Lesson Overview. Lesson Overview Studying the Human Genome
Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful
More informationKnowing changes everything.
SYRACUSE, NEW YORK CLINICAL UPDATE May 2009 $6.2 million for Stem Cell Research SUNY Upstate s well-established stem cell research program receives a massive boost from NYSTEM. GPS for Prostate University
More informationA unique Collaborative Model for the Discovery of New Therapeutic Approaches
A unique Collaborative Model for the Discovery of New Therapeutic Approaches THE INNOVATION GAP OPEN INNOVATION TO ADDRESS THE LACK OF PRODUCTIVITY OF BIOPHARMACEUTICAL RESEARCH A PRE-COMPETITIVE PHARMA
More informationGenetics Lecture 21 Recombinant DNA
Genetics Lecture 21 Recombinant DNA Recombinant DNA In 1971, a paper published by Kathleen Danna and Daniel Nathans marked the beginning of the recombinant DNA era. The paper described the isolation of
More informationState of Texas Assessments of Academic Readiness (STAAR ) Performance Level Descriptors Biology
State of Texas Assessments of Academic Readiness (STAAR ) Biology Scientific process skills are not assessed in isolation but are incorporated into questions that assess the biology content. These process
More informationORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS
ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS 2018-2024 ORACLE 2.0: Leading Globally, from Innovation to Impact P1 P2 NOTE FROM OUR LEADERS NOTE FROM VP RESEARCH,
More informationThe Power to Cure: Therapeutic Innovation in Academia
The Power to Cure: Therapeutic Innovation in Academia Leslie Molony, Ph.D. November 7, 2011 Sanford-Burnham Medical Research Institute: a Non Profit Basic Research Institute Santa Barbara Est. 2006 La
More informationUCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA
UCF, College of Medicine BS Biotechnology MS Biotechnology/MBA Professional Science Masters Program in Biotechnology/MBA Dr. Henry Daniell Pegasus Professor & University Board of Trustee Chair Dept. Mol.
More informationDr Timothy Johanssen, Alzheimer's Research UK Drug Discovery Institute
Turning Discoveries at the Bench in to Therapies for Dementia Dr Timothy Johanssen, Alzheimer's Research UK Drug Discovery Institute Hi, My name's Tim Johannsen. I'd like to thank Melanie Witt and Mark
More informationUAMS ADVANCED DIAGNOSTICS FOR ADVANCING CURE
UAMS ADVANCED DIAGNOSTICS FOR ADVANCING CURE advanced diagnostics for advancing cure Multiple myeloma (myeloma) is a complex cancer that can be diffcult to diagnose and challenging to treat. Every case
More informationBone Marrow Failure Research Program
Bone Marrow Failure Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military, and
More informationGenetic tests are available for hundreds of disorders. DNA testing can pinpoint the exact genetic basis of a disorder.
Human DNA Analysis Human DNA Analysis There are roughly 6 billion base pairs in your DNA. Biologists search the human genome using sequences of DNA bases. Genetic tests are available for hundreds of disorders.
More informationCANCER RESEARCH: Down to the Basics
CANCER RESEARCH: Down to the Basics At Caltech it is an accepted fact that, in the long run, basic research is often the best kind of applied research. Although the results of a scientist's investigations
More informationMaster of Science in Biotechnology Program. ms-biotech.wisc.edu November 8, 2017
Master of Science in Biotechnology Program ms-biotech.wisc.edu November 8, 2017 Program Mission: An integrated curriculum in science, policy, law and business preparing students to LEAD the development
More informationSSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview
SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy
More informationThe Integrated Biomedical Sciences Graduate Program
The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to
More informationBasic Information. I.1 If your company performs biotechnology research and development, uses a. The Categories of Biotechnology Applications.
APPENDIX 2 SURVEY QUESTIONNAIRE Part I. Basic Information I.1 If your company performs biotechnology research and development, uses a biotechnology process in manufacturing, or produces research tools,
More informationFederal Funding for Brain Research. Congressional Support Accelerates Discovery
The American Brain Coalition (ABC) is a non-profit organization that brings together people with disabling brain disorders, the families of those that are affected, and the professionals who research and
More informationHigher National Diploma Biomedical Science
BMS is committed to developing scientists for the betterment of our country Higher National Diploma Biomedical Science leading to final year of BSc (Hons) Biomedical Science Committed to supporting students
More informationDepartment of Biochemistry and Molecular Genetics
536 Department of Biochemistry and Molecular Genetics Chairperson: Professors: Associate Professors: Assistant Professors: Associates: Jaffa, Ayad Boustany, Rose-Mary; Darwiche, Nadine; Dbaibo, Ghassan;
More informationInstitute for the Environment
2015-2019 STRATEGIC PLAN Institute for the Environment THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL LETTER FROM THE DIRECTOR Developing solutions to meet the world s growing environmental and energy
More informationChapter 8 Healthcare Biotechnology
Chapter 8 Healthcare Biotechnology Outline: 8.1 Introduction 8.2 Biopharming 8.3 Models of Human Disease 8.4 Detecting and Diagnosing Human Disease 8.5 Monoclonal Antibodies 8.6 Gene Therapy 8.7 Tissue
More informationScience Education & Communication. Dennis A. Ausiello, MD President Association of American Physicians
Science Education & Communication Dennis A. Ausiello, MD President Association of American Physicians Biology The framework for understanding the function of an organism The "theology" of our profession
More informationManitoba Centre for Proteomics and Systems Biology 10th Anniversary
Manitoba Centre for Proteomics and Systems Biology 10th Anniversary Originally published in HSC Focus Volume 23, Number 6 September 23, 2016 Collaborative and Patient-Oriented Research At HSC Winnipeg,
More informationProcess and guidelines for applications for approval of trials involving gene and other biotechnology therapies. November 2015
Process and guidelines for applications for approval of trials involving gene and other biotechnology therapies November 2015 HRC Gene Technology Advisory Committee For further information contact: Professor
More informationPost-doctoral PharmD Fellowship Programs
Post-doctoral PharmD Fellowship Programs Table of Contents About Bioverativ Messages from Medical & Regulatory Our Pipeline Partnership with Northeastern University Global Medical Fellowship Global Regulatory
More informationBIOTECHNOLOGY CENTER FOR A NEWYORK STATE CENTER FOR ADVANCED TECHNOLOGY
BIOTECHNOLOGY CENTER FOR A NEWYORK STATE CENTER FOR ADVANCED TECHNOLOGY V I S I O N Through recent major advances in the understanding of biology, the 21st c e n t u ry will witness profound technological
More informationOn behalf of the Cystic Fibrosis Foundation (CFF) and the 30,000 people with cystic
Robert J. Beall, Ph.D. President and Chief Executive Officer Cystic Fibrosis Foundation On behalf of the Cystic Fibrosis Foundation (CFF) and the 30,000 people with cystic fibrosis (CF) in the United States,
More informationComputers in Biology and Bioinformatics
Computers in Biology and Bioinformatics 1 Biology biology is roughly defined as "the study of life" it is concerned with the characteristics and behaviors of organisms, how species and individuals come
More informationConference Exhibitors
Conference Exhibitors CSM Executive and the 2018 Manitoba Local Organizing Committee would like to thank the following organizations for exhibiting and supporting the Canadian Society of Microbiologists
More informationThe Role of the NIH Clinical Center in Translational and Clinical Research
The Role of the NIH Clinical Center in Translational and Clinical Research International Conference on Engineering Science and Technology 2014 John I. Gallin, M.D. Director, NIH Clinical Center Associate
More informationScience TEKS Verification
Science EKS Verification (1) Scientific processes. he student, for at least 40% of instructional time, conducts laboratory and field investigations using safe, environmentally appropriate, and ethical
More informationResearch Assistant (Complex Trait Genomics)
POSITION DESCRIPTION Position Title: Research Assistant (Complex Trait Genomics) Organisation Unit: Institute for Molecular Bioscience Position Number: 3026880 Type of Employment: Full time, fixed term
More informationNational Health Research Institutes
National Health Research Institutes October 2008 History The founding of the National Health Research Institutes (NHRI) was first proposed in 1988 by members of Academia Sinica. In 1994 a preparatory committee
More informationJ ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION
J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION J ove VIDEO JOURNAL The first scientific video journal dedicated to advancing science by increasing reproducibility and efficient
More informationTHE WHITE HOUSE Office of the Vice President
FOR IMMEDIATE RELEASE October 17, 2016 THE WHITE HOUSE Office of the Vice President FACT SHEET: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance
More informationBIOLOGICS & PROCESS TECHNOLOGY MASTER CLASS
BIOLOGICS & PROCESS TECHNOLOGY MASTER CLASS Supported By: Organised By: PROGRAMME OVERVIEW BIOLOGICS MAKE UP MORE THAN 1,000 MEDICINES AND VACCINES THAT TARGET MORE THAN 100 DISEASES. Unlike medicines
More informationScientists don t yet fully
Alzheimer s Disease Genetics FACT SHEET Scientists don t yet fully understand what causes Alzheimer s disease. However, the more they learn about this devastating disease, the more they realize that genes*
More informationUniversity of Pennsylvania Perelman School of Medicine High Throughput Screening Core
University of Pennsylvania Perelman School of Medicine High Throughput Screening Core Sara Cherry, Ph. D. David C. Schultz, Ph. D. dschultz@mail.med.upenn.edu (215) 573 9641 67 John Morgan Building Mission
More informationA PMP Among PhDs: Applying Program Management to Biotechnology Research and Commercialization Speaker: Jill Almaguer, PE, MBA, PMP Company: Texas
A PMP Among PhDs: Applying Program Management to Biotechnology Research and Commercialization Speaker: Jill Almaguer, PE, MBA, PMP Company: Texas Heart Institute Website: www.texasheart.org, www.ccobtexas.org
More informationAG RESEARCH AT PURDUE. People. Making an Impact
AG RESEARCH AT PURDUE People Making an Impact BUILD UTILIZE DEVELOP ENHANCE STRENGTHEN FACILITATE urdue Agriculture is people talented faculty, dedicated staff, and motivated students who grow into an
More informationRenew, Repair, Rejuvenate. Presented by: Clinton Howard at the 2012 Leadership Retreat Maui, Hawaii, September 29, 2012
Stem-Kine Renew, Repair, Rejuvenate Presented by: Clinton Howard at the 2012 Leadership Retreat Maui, Hawaii, September 29, 2012 I am pleased to have the opportunity to talk with you about one of the most
More informationVision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University
Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through
More informationCSC 121 Computers and Scientific Thinking
CSC 121 Computers and Scientific Thinking Fall 2005 Computers in Biology and Bioinformatics 1 Biology biology is roughly defined as "the study of life" it is concerned with the characteristics and behaviors
More informationSTEM CELL RESEARCH EBENEZER ANOM ENGLISH 1311 CLASS UNIVERSITY OF TEXAS AT EL PASO
STEM CELL RESEARCH BY EBENEZER ANOM ENGLISH 1311 CLASS UNIVERSITY OF TEXAS AT EL PASO ABSTRACT In our communities today, relatives, neighbors, friends and even those we don t know have been incapacitated
More informationGenetics 101. Prepared by: James J. Messina, Ph.D., CCMHC, NCC, DCMHS Assistant Professor, Troy University, Tampa Bay Site
Genetics 101 Prepared by: James J. Messina, Ph.D., CCMHC, NCC, DCMHS Assistant Professor, Troy University, Tampa Bay Site Before we get started! Genetics 101 Additional Resources http://www.genetichealth.com/
More informationMicrobiology, Molecular Biology and Biochemistry
Microbiology, Molecular Biology and Biochemistry Bruce L. Miller, Interim Dept. Head, Dept. of Microbiology, Molecular Biology and Biochemistry (142 Life Sc. Bldg. 83844-3052; phone 208/885-7966; mmbb@uidaho.edu;
More informationEmployment in the biopharma industry grew almost 5 percent in 2014, the last full year for which we have data. This is the highest annual growth rate
Thank you, Mr. Chairman, and members of the committee. I m Sarah MacDonald, Executive Vice President at MassBio, the life sciences trade association now representing over 700 member organizations. First,
More informationREIMAGINING DRUG DEVELOPMENT:
Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY
More informationTHE CRISPR-CAS9 DISPUTE
WHO OWNS THE INTELLECTUAL PROPERTY? THE CRISPR-CAS9 DISPUTE UTRF Tech Talks Dr. Lakita Cavin February 23, 2017 WHAT IS CRISPR-Cas9 Clustered Regularly-Interspaced Short Palindromic Repeats/CRISPR associated
More informationNEW DRUG FORMULATIONS TO BOOST FIGHT AGAINST RESPIRATORY ILLNESSES AND ANTIBIOTIC-RESISTANT SUPERBUGS
MEDIA RELEASE FOR IMMEDIATE RELEASE 15 September 2014 NEW DRUG FORMULATIONS TO BOOST FIGHT AGAINST RESPIRATORY ILLNESSES AND ANTIBIOTIC-RESISTANT SUPERBUGS A team from A*STAR s Institute of Chemical and
More informationA New Cellular and Molecular Engineering Curriculum at Rice University
Session A New Cellular and Molecular Engineering Curriculum at Rice University Ka-Yiu San, Larry V. McIntire, Ann Saterbak Department of Bioengineering, Rice University Houston, Texas 77005 Abstract The
More informationShort Course Instructors
Short Course Instructors Andrew Allen, Ph.D., Professor of Biostatistics and Bioinformatics and Director of the new Duke Center of Statistical Genetics and Genomics, Duke University, has expertise in statistical
More informationDuncanrig Secondary School
National 4 Biology Unit 1Topic 3: Therapeutic Uses of Cells, Duncanrig Secondary School Duncanrig Secondary School National 4 Biology Unit 1 Topic 3: Therapeutic Uses of Cells Pupils Activity Booklet National
More informationIntroducing the Department of Life Sciences
Introducing the Department of Life Sciences Life Sciences is a discipline that aims at a fundamental understanding of life phenomena by exploring complex and mysterious structures and funct ions of living
More informationMANIFESTO OF STUDIES 2012
MANIFESTO OF STUDIES 2012 1st YEAR Course Teacher Hours Synopsis Evaluation procedure Laboratory Safety Course (Mandatory) Prof. Mancini I. Dr. Provenzani A. 12 General Laboratory Procedures, Equipment
More informationBIOTECHNOLOGY. Understanding the Application
BIOTECHNOLOGY Understanding the Application GENETIC ENGINEERING Genetic engineering refers to any process in which man alters an organism s DNA Examples: cloning, genetically modified organisms (GMO),
More informationBGEN Laboratory Methods in Human and Medical Genetics
BMG COURSES BGEN 7000 - Research Seminar MSc Consists of presentations of the student's current research. For Master s students only. 1.0 credit hours. BGEN 7020 Proteins (Formerly 137.702) Three hours
More informationImpact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation
Impact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation Outline What is GNF? Approach How it works The need for collaborative robots
More information6th Form Open Day 15th July 2015
6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine
More informationDOCTOR OF PHILOSOPHY PROGRAM IN ORAL BIOLOGY
Doctor of Philosophy Program in Oral Biology FACULTY OF DENTISTRY Naresuan University 183 Doctor of Philosophy Program in Oral Biology Oral biology at Naresuan University covers the study of the structure
More information